The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.
This is the first study to specifically examine remdesivir as a treatment for LC.
The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.
This is the first study to specifically examine remdesivir as a treatment for LC.
Crazy that we're still stuck on the idea of monotherapy.
The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.
This is the first study to specifically examine remdesivir as a treatment for LC.
Crazy that we're still stuck on the idea of monotherapy.
(Surgisphere, remdesivir, pangolin, je vous confirme ils ont été cryogénisés en 2020 !)
(Surgisphere, remdesivir, pangolin, je vous confirme ils ont été cryogénisés en 2020 !)
Madrid study shows combination therapy (Remdesivir + Paxlovid ± Sotrovimab) clears infection and overcomes resistance. buff.ly/tqlmc0I
Personalized antiviral strategies matter.
#medsky #IDsky #publichealth #oncsky
Madrid study shows combination therapy (Remdesivir + Paxlovid ± Sotrovimab) clears infection and overcomes resistance. buff.ly/tqlmc0I
Personalized antiviral strategies matter.
#medsky #IDsky #publichealth #oncsky
Systematic review & meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: academic.oup.com/cid/article/...
Systematic review & meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: academic.oup.com/cid/article/...
Notably, he is not treated with hydroxychloroquine or ivermectin, the quack cures he urged on his fans.
Notably, he is not treated with hydroxychloroquine or ivermectin, the quack cures he urged on his fans.
The ERASE_LC trial evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.
This is the first study to specifically examine remdesivir as a treatment for LC.
The ERASE-LC trial is making steady progress. All participants have now received their infusions of remdesivir and completed their post-treatment testing.
The ERASE-LC trial is making steady progress. All participants have now received their infusions of remdesivir and completed their post-treatment testing.
#IDSky
#MedSky
@ebhirsch.bsky.social
academic.oup.com/cid/advance-...
#IDSky
#MedSky
@ebhirsch.bsky.social
academic.oup.com/cid/advance-...
www.medscape.com/viewarticle/...
www.medscape.com/viewarticle/...
Risk was about 25% lower ⬇️ with early initiation in infected patients with either chronic disease who received supplemental oxygen.
Read more: https://bit.ly/46zvHYz
Risk was about 25% lower ⬇️ with early initiation in infected patients with either chronic disease who received supplemental oxygen.
Read more: https://bit.ly/46zvHYz
Key feasibility findings:
✅ 97% completed the full 5-day remdesivir course
✅ 96% completed follow-up assessments
✅ High engagement with outcome measures and symptom tracking
Key feasibility findings:
✅ 97% completed the full 5-day remdesivir course
✅ 96% completed follow-up assessments
✅ High engagement with outcome measures and symptom tracking
This is my beautiful mum, who died of hospital acquired Covid in 2022. It’s nice to not get a slew of ‘she was sick anyway/gonna die soon/how fat was she/Remdesivir killed her’ comments.
This is my beautiful mum, who died of hospital acquired Covid in 2022. It’s nice to not get a slew of ‘she was sick anyway/gonna die soon/how fat was she/Remdesivir killed her’ comments.
▫️44/ #faucihearing
▫️44/ #faucihearing
An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial
dx.doi.org/10.1093/oxfi...
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19
An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial
dx.doi.org/10.1093/oxfi...
Screenshot from latest Science for ME weekly update
#LongCovid #PASC #PwLC #postcovid #postcovid19
He's not a virologist.
His wife invested in Remdesivir at the peak of Covid as he pushed the drug on Americans. They didn't disclose their investment for 16 months.
They made a fortune.
Always the $.
shorturl.at/G5LW7
He's not a virologist.
His wife invested in Remdesivir at the peak of Covid as he pushed the drug on Americans. They didn't disclose their investment for 16 months.
They made a fortune.
Always the $.
shorturl.at/G5LW7